戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 t that completes its lifecycle (e.g. another mosquito bite).
2  with sylvatic strains of DENV-2 or ZIKV via mosquito bite.
3 kungunya virus, an alphavirus transmitted by mosquito bite.
4 by abrogating transmission to naive mice via mosquito bite.
5 zoites either intravenously or by infectious mosquito bite.
6 ted during probing of human skin by infected-mosquito bite.
7  transmitted to the vertebrate host during a mosquito bite.
8 cohort of CD8(+) T cells after an infectious mosquito bite.
9 e transmitted to the mammalian host during a mosquito bite.
10  used as biomarkers of exposure to Anopheles mosquito bites.
11 ughput molecular interrogation of individual mosquito bites.
12 nting behavior helps to protect cats against mosquito bites.
13  due to heterogeneous exposure to infectious mosquito bites.
14 yaro virus particles transmitted from single mosquito bites.
15 iomarkers of exposure to Anopheles and Aedes mosquito bites.
16 ived primaquine, chloroquine, and uninfected mosquito bites.
17  transmitting the disease are protected from mosquito bites.
18  functional materials for protection against mosquito bites.
19 h no history of severe allergic reactions to mosquito bites.
20        Four patients had hypersensitivity to mosquito bites.
21 smodium falciparum (Pf) sporozoites (SPZ) by mosquito bites.
22 iable and prolonged complete protection from mosquito bites.
23 o seek safe and effective ways of preventing mosquito bites.
24 istamines to minimize cutaneous reactions to mosquito bites.
25 risk of these diseases in humans by reducing mosquito biting.
26 enesis.IMPORTANCE When a Zika virus-infected mosquito bites a person, mosquito saliva is injected int
27           Moreover, among mice challenged by mosquito bite, a higher proportion of BALB/c mice than C
28 es preventing every sporozoite inoculated by mosquito bite: a major challenge for Plasmodium falcipar
29  localized urticaria related to the numerous mosquito bites administered per vaccination.
30 indications such as acquired cold urticaria, mosquito bite allergy and mastocytosis.
31 ailed to clear viremia until day 56, while a mosquito bite alone induced strong immunomodulators (tum
32          Human infections are typically from mosquito bites, although cases from respiratory exposure
33                                              Mosquito biting among humans is 90-10 at the lowest tran
34 ho may exhibit cutaneous hypersensitivity to mosquito bite and to others who may have not yet develop
35 types, and pathways in the human response to mosquito bites and can be leveraged to inform and develo
36  demonstrated indoor and outdoor exposure to mosquito bites and gaps in protection, enabling exposure
37 ould be used as markers of human exposure to mosquito bites and in the development of disease control
38               Zika virus (ZIKV) is spread by mosquito bites and is unique among known flaviviruses fo
39  Zika virus (ZIKV) is transmitted mostly via mosquito bites and no vaccine is available, so it may re
40 y protect individuals against infection from mosquito bites and provide transmission-blocking (TB) ac
41 ecticide were highly effective in preventing mosquito bites and reducing transmission, and essential
42 es list can provide complete protection from mosquito bites and tick crossings for longer than one ho
43 il provided the longest protection from both mosquito bites and tick crossings.
44 irus (ZIKV) is primarily transmitted through mosquito bites and, occasionally, via breast milk, makin
45  to assess the occupational exposure risk of mosquito biting and arbovirus transmission among outdoor
46 ozoite transmission to the mammalian host by mosquito bite, and subsequent infection of the liver are
47 ons, the number of clones inoculated at each mosquito bite, and the duration of infections.
48  25 drug-resistance related loci, individual mosquito bites, and mosquitoes feeding on multiple hosts
49 y the human skin microbiota that may curtail mosquito bites, and subsequent mosquito-borne disease.
50 er are febrile illnesses transmitted through mosquito bites, and these common features make it diffic
51                        Allergic reactions to mosquito bites are an increasing clinical concern.
52  In view of these findings and the fact that mosquito bites are the natural mode of sporozoite delive
53       Pf sporozoites (PfSPZ) administered by mosquito bites are the only immunogens shown to induce s
54            Anecdotes related to preferential mosquito bites are very common, but to date there is no
55 an Malaria Infection (CHMI) was delivered by mosquito bite at Imperial College London, London, UK, 3-
56         Substantial spatial heterogeneity in mosquito biting behavior between communities could contr
57 ry state are highly effective at suppressing mosquito biting behavior on live human skin.
58 yses and discrete choice models, we assessed mosquito biting behavior with respect to parasite transm
59 ect of the human environment that influences mosquito biting behaviour and malaria transmission, and
60 nsities, although the uneven distribution of mosquito bites between hosts could also contribute.
61 ural dengue virus (DENV) infections occur by mosquito bite but how the inoculation route affects the
62 f mice when sporozoites were administered by mosquito bite but not when they were administered by int
63 de of ZIKV transmission to humans is through mosquito bites, but sexual transmission has also been we
64          Almost all WNV infection occurs via mosquito bites, but transmission can rarely occur via bl
65 hesize that differences in responsiveness to mosquito bite by different individuals might modulate th
66  liver-stage development and transmitted via mosquito bites, can induce substantial protection agains
67  we observe species-dependent differences in mosquito biting capacity, utilizable for selective sampl
68 n PfCSP mAbs at mediating protection against mosquito bite challenge in mice.
69    Serum antibody levels and protection from mosquito bite challenge were dependent on the dose of th
70  up to 70% were protected from both i.v. and mosquito bite challenge with transgenic Plasmodium bergh
71  However, inhibition was most potent for the mosquito bite challenge, leading to a more significant r
72 -DEAL also enhanced protection of mice after mosquito bite challenge.
73    When malaria infection was initiated from mosquito bites, coinfected animals displayed increased m
74 iomarkers of exposure to Anopheles and Aedes mosquito bites could be helpful tools for evaluating the
75  immunization with sporozoites from infected mosquitoes' bites (CPS protocol).
76              Here we show that infection via mosquito bite delays ZIKV replication to peak viral load
77 ed mice with humanized livers from i.v.- and mosquito bite-delivered P. falciparum sporozoite challen
78                                              Mosquito biting does not occur uniformly throughout the
79 be achieved by repeated exposure to infected mosquito bites during prophylactic chloroquine treatment
80 areas, where people are exposed to Anopheles mosquito bites during the day and night.
81 viral inoculation occurs in the skin via the mosquito 'bite', eliciting immune responses that shape t
82 ptides as validated biomarkers of respective mosquito bite exposure.
83 oybean-oil-based repellent protected against mosquito bites for an average of 94.6 minutes.
84 say to measure complete protection time from mosquito bites for these active ingredients.
85 h radiation-attenuated sporozoites (RAS) via mosquito bites has been shown to induce sterile immunity
86  human malaria infection (CHMI) initiated by mosquito bite have been widely used to assess efficacy o
87 eous inoculation, as would occur following a mosquito bite, have historically been limited by a lack
88                         Female Aedes aegypti mosquitoes bite humans to obtain blood to develop their
89 quito at day 42 to assess subsequent risk to mosquito bites in a controlled setting.
90 ned by diseases that are transmitted through mosquito bites, including dengue, Zika, and malaria.
91 udicious use of pesticides; and avoidance of mosquito bites, including mosquito repellent use.
92 prophylactic measures to reduce or eliminate mosquito bites, including the use of insect repellents.
93 ease in the number of potentially infectious mosquito bites, increased partial blood-feeding and redu
94 is explains susceptibility to reinfection by mosquito bite, independent of blood stage-induced immuno
95 profiles and adverse events (AEs), following mosquito bite-induced PvCHMI in malaria-naive study part
96 ns to rAed a 3 correlated significantly with mosquito bite-induced reactions.
97 e individuals exposed to a single controlled mosquito bite infection.
98              This study identifies facets of mosquito bite inflammation that are important determinan
99 Intensity of exposure to infective Anopheles mosquito bites is a suspected determinant of higher dens
100 , suggesting that superinfection by repeated mosquito bites is rarer than co-transmission of parasite
101 , vaccine candidates could be transmitted by mosquito bite, leading to asymptomatic infection in mice
102 ciency, the latter resulting in the infected mosquitoes biting more to reach similar blood repletion
103 fficacy of CIS43 GL and 317 GL in a rigorous mosquito bite mouse challenge model.
104 ns induced by IBSM (n = 66), sporozoites via mosquito bite (n = 336), or injection (n = 51).
105 approximately 10(6) PFU, the equivalent of a mosquito bite) of these humanized mice with eight low-pa
106 ined lower than those in hosts that received mosquito bites only at the time of infection.
107 mia in a dose-dependent manner, and a single mosquito bite or as little as 0.01 mug of SGE was effect
108      Zika virus (ZIKV) can be transmitted by mosquito bite or sexual contact.
109 ent models that initiate infection either by mosquito bite or using a blood-stage inoculum.
110 ual spraying (IRS)-primarily protect against mosquitoes' biting people when they are in bed and indoo
111 a were randomly assigned to be exposed to 50 mosquito bites per immunization of GA2, an early-arresti
112 8) immunizations with ~200 PfGAP3KO-infected mosquito bites per immunization.
113 etion of three immunization sessions with 50 mosquito bites per session, we compared the protective e
114                                  Following a mosquito bite, Plasmodium sporozoites migrate from skin
115 n efficiency during vector-human contact and mosquito biting preferences.
116  offer an additional unanticipated function: mosquito bite protection for light, fiber-based fabrics.
117 ures should be targeted towards reducing the mosquito biting rate.
118                                         High mosquito biting rates, living in a house with someone el
119 ining data with spatially explicit models of mosquito biting rates, we demonstrate the role of indivi
120  association studies (GWAS) of self-reported mosquito bite reaction size (n = 84,724), itchiness caus
121                                Heterogeneous mosquito biting results from variations in both host att
122 microbiota are likely affected by changes in mosquito biting rhythms.
123 ural mode of sporozoite delivery, infectious mosquito bites should be considered the challenge protoc
124 tern blots, bite blots, and immunization via mosquito bites showed that SGSs are highly immunogenic a
125 ate that NeSt1 stimulates neutrophils at the mosquito bite site to change the immune microenvironment
126              The inoculation of viruses into mosquito bite sites is an important and common stage of
127 ed by virus-susceptible myeloid cells toward mosquito bite sites, which facilitates establishment of
128  those in mice infected by a single infected mosquito bite, suggesting that differences in where viru
129                                              Mosquito bites taken outside of these times contribute t
130 se it more closely mimics human infection by mosquito bite than needle-based inoculations.
131 t of two people systematically receives more mosquito bites than the other when both are equally acce
132 odies are emerging biomarkers of exposure to mosquito bites that potentially overcome sensitivity and
133                  During an infection through mosquito bite, the infectivity of the knock-out parasite
134 mosquitoes than children, they received more mosquito bites, thus balancing their contribution to the
135  interference (RNAi) and are transmitted via mosquito bite to a subsequent host.
136                        CHMI was delivered by mosquito bites to 33 vaccinated subjects at week 12 afte
137                       We observed a shift in mosquito biting to earlier hours of the evening, before
138                                              Mosquito bites transmit a number of pathogens via saliva
139 n which IL-4 is released) that accompany the mosquito bites transmitting the virus.
140     Immunization with Plasmodium chabaudi by mosquito bite under chloroquine cover does not generate
141  Plasmodium berghei sporozoites delivered by mosquito bite were more infectious to outbred CD-1 mice
142                                              Mosquito bites were characterized by an edema that retai
143  controls received a sporozoite challenge by mosquito bites, whereas nine immunized and five control
144 fection initiated by sporozoites injected by mosquito bite which elicits both neutralizing antibodies
145 e, and efficacy of immunization, by means of mosquito bites, with a second-generation genetically att
146 stochastic framework for repeated infectious mosquito bites, with seasonality inferred from the incid

 
Page Top